Designed for outstanding performance in all three areas of hemodynamics, durability and implantability, the Trifecta valve demonstrates our passion for putting more control into the hands of physicians.
Learn more about the Trifecta manufacturing process and quality measures.
Created exclusively for the aortic position, the Trifecta valve delivers larger EOAs, resulting in single-digit pressure gradients.1 The Trifecta valve is designed to mimic the flow of a natural, healthy heart valve and offers excellent hemodynamic performance, which may provide patients with an improved quality of life.

In vivo single-digit mean gradients averaged across all valve sizes at six months.1
Large EOAs across all valve sizes result in decreased risk of patient-prosthesis mismatch at six months.1
With more than 30 years of market experience, the Trifecta valve was designed for long-term durability and performance. The result is a design that has demonstrated excellent in vitro wear testing.2
1. Pericardial covered stent for tissue-to-tissue contact reducing
the risk of abrasion and structural valve deterioration.2
2. Elimination of tacking suture at top of commissure reduces risk
of tearing.
3. Proper leaflet shaping and coaptation are achieved through
proprietary tissue leaflet fixation.2
4. Leaflets from a single pericardial sheet, externally mounted,
optimize coaptation and maximize flow.
Fatigue-resistant, high-strength titanium stent designed to reduce stress on leaflets during cardiac cycle.2
- Contoured silicone insert within a unique polyester cuff is designed to conform to the shape of the native annulus for proper seating and to reduce the risk of PV leak.1
- Trifecta valve sizers are optimized for true-to-size selection.
- Efficient 2 x 10-second rinse.
- Aortic valve holder improves visibility and cuff access for suturing.
- Both the flexible and rigid valve holder handles provide quick, click-in handle attachment and removal to stabilize the valve and minimize the risk of unseating.
1. St. Jude Medical. Trifecta Valve, Pre-Market Approval Application Summary of Safety and Effectiveness Data, P100029, 2011.
2. Data on File, St. Jude Medical.